News

As of the expiration of the subsequent offering period, Rocket Acquisition Corporation, a wholly-owned subsidiary of Roche, had purchased a total of approximately 34.54 million shares of Ventana

Xyzal tablets received FDA approval on May 25, 2007 and both formulations are now approved for use in adults and children 6 years and older. Studies in allergic

Bon Secours will be implementing CrossWalk to connect its hospitals’s supply item files and chargemasters, thus enabling a process by which mark-up strategies can be modeled before implementation

The $1 million payment has been triggered with the significant progress made in the first stage of evaluation of the licensed proteins. This evaluation strongly supported the potential

The first patients in a 600-patient Phase II study have been enrolled. The study will investigate the effects of Lu AA34893 on the depressive episodes in bipolar disorder

Trinity Health will be using Capsule’s DataCaptor Connectivity Suite to automate the capture of patient data from bedside devices, including GE Monitors from the Unity network. DataCaptor collects

The Phase III ESCAPE (Evaluation of Sorafenib, Carboplatin And Paclitaxel Efficacy in NSCLC) trial evaluated Nexavar when administered in combination with the chemotherapeutic agents carboplatin and paclitaxel in

MRX-4 was nasally administered as a single dose once a week for four consecutive weeks. The first administration was given without a nasal allergen challenge (NAC) while the

The license represents an extension of the existing license of all the GVK Bio Target and Drug databases. The GVK Bio databases contain over 3.2 million compounds manually